COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1926: Articles 19251-19260  | Next

Identical trends of SARS-Cov-2 transmission and retail and transit mobility during non-lockdown periods
Cazelles, B., Comiskey, C., Nguyen Van Yen, B., Champagne, C., Roche, B.
10.1101/2020.12.29.20248990 — Posted: 2021-01-04
Unsupervised Discovery of Risk Profiles on Negative and Positive COVID-19 Hospitalized Patients
Nezhadmoghadam, F., Tamez-Pena, J.
10.1101/2020.12.30.20248908 — Posted: 2021-01-04
Lockdown Effects on Sars-CoV-2 Transmission - The evidence from Northern Jutland
Kepp, K. P., Bjornskov, C.
10.1101/2020.12.28.20248936 — Posted: 2021-01-04 Discussion: Onsite
Cardiometabolic risks of SARS-CoV-2 hospitalization using Mendelian Randomization
Lorincz-Comi, N. J., Zhu, X.
10.1101/2020.12.30.20248889 — Posted: 2021-01-04
Co-circulation of SARS-CoV-2 and Influenza under vaccination scenarios
Acuna Zegarra, M. A., Nunez Lopez, M., Santana Cibrian, M., Comas Garcia, A., Velasco-Hernandez, J. X.
10.1101/2020.12.29.20248953 — Posted: 2021-01-04
Percentage of reported Covid-19 cases in Colombia: Estimating the true scale of the pandemic
Parra, N., Vargas-Calderon, V., Florez, J. S., Ardila, L., Viviescas, C.
10.1101/2020.12.30.20249052 — Posted: 2021-01-04
COVID Outcome Prediction in the Emergency Department (COPE)
van Klaveren, D., Rekkas, A., Alsma, J., Verdonschot, R. J., Koning, D. T., Kamps, M. J., Dormans, T., Stassen, R., Weijer, S., Arnold, K.-S., Roelink, M., Schuit, S. C., Lingsma, H.
10.1101/2020.12.30.20249023 — Posted: 2021-01-04
Imprecise assessment of mask use may obscure associations with SARS-CoV-2 positivity
Berube, S., Clipman, S., Mehta, S. H., Solomon, S., Wesolowski, A.
10.1101/2020.12.30.20249033 — Posted: 2021-01-04 Discussion: Offsite
Insights into the molecular mechanism of anticancer drug ruxolitinib repurposable in COVID-19 therapy
Mandal, M., Mandal, S.
10.1101/2020.12.29.20248986 — Posted: 2021-01-04
PREDICTORS OF UPTAKE OF A POTENTIAL COVID-19 VACCINE AMONG NIGERIAN ADULTS
Olomofe, C. O., Soyemi, V. K., Udomah, B. F., Owolabi, A. O., Ajumuka, E. E., Igbokwe, C. M., Ashaolu, U. O., Adeyemi, A. O., Aremu-Kasumu, Y. B., Dada, O. F., Ochieze, J. C., Fayemi, O. B., Ologunde, K. W., Popoola, O. G., Ariyo, O. E.
10.1101/2020.12.28.20248965 — Posted: 2021-01-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).